Table 2 In vitro antimicrobial activity of the synthesized compounds
Comp. | Antimicrobial screening (MIC = µM) | |||||
|---|---|---|---|---|---|---|
SA | BS | EC | ST | CA | AN | |
H1 | 32.7 | 32.7 | 65.4 | 32.7 | 32.7 | 32.7 |
H2 | 77.8 | 38.9 | 38.9 | 38.9 | 38.9 | 38.9 |
H3 | 62.9 | 15.7 | 31.4 | 31.4 | 31.4 | 15.7 |
H4 | 30.0 | 15.0 | 60.0 | 15.0 | 30.0 | 30.0 |
H5 | 13.2 | 26.3 | 52.7 | 26.3 | 26.3 | 26.3 |
H6 | 32.3 | 32.3 | 32.3 | 32.3 | 32.3 | 32.3 |
H7 | 31.5 | 15.8 | 63.1 | 31.5 | 31.5 | 31.5 |
H8 | 63.1 | 31.5 | 63.1 | 31.5 | 31.5 | 31.5 |
H9 | 60.9 | 30.5 | 60.9 | 30.5 | 30.5 | 30.5 |
H10 | 60.9 | 15.2 | 60.9 | 30.5 | 30.5 | 30.5 |
H11 | 31.2 | 31.2 | 15.6 | 15.6 | 31.2 | 31.2 |
H12 | 54.2 | 27.1 | 54.2 | 13.5 | 27.1 | 27.1 |
H13 | 29.2 | 29.2 | 58.5 | 29.2 | 29.2 | 7.3 |
H14 | 27.1 | 27.1 | 54.1 | 27.1 | 27.1 | 13.5 |
H15 | 15.2 | 30.3 | 15.2 | 15.2 | 30.3 | 30.3 |
H16 | 30.3 | 30.3 | 60.6 | 30.3 | 30.3 | 15.2 |
H17 | 15.2 | 30.3 | 30.3 | 30.3 | 30.3 | 30.3 |
H18 | 15.6 | 7.8 | 31.2 | 7.8 | 31.2 | 7.8 |
H19 | 58.5 | 29.2 | 58.5 | 29.2 | 29.2 | 29.2 |
Cefadroxil | 34.4 | 34.4 | 17.2 | 34.4 | – | – |
Fluconazole | – | – | – | – | 40.8 | 40.8 |